SE0101230L - Ny användning av en tyrosinkinasinhibitor - Google Patents

Ny användning av en tyrosinkinasinhibitor

Info

Publication number
SE0101230L
SE0101230L SE0101230A SE0101230A SE0101230L SE 0101230 L SE0101230 L SE 0101230L SE 0101230 A SE0101230 A SE 0101230A SE 0101230 A SE0101230 A SE 0101230A SE 0101230 L SE0101230 L SE 0101230L
Authority
SE
Sweden
Prior art keywords
tyrosine kinase
frk
inhibitor
relates
type
Prior art date
Application number
SE0101230A
Other languages
Unknown language ( )
English (en)
Other versions
SE0101230D0 (sv
Inventor
Michael Welsh
Cecilia Anneren
Original Assignee
Innoventus Project Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innoventus Project Ab filed Critical Innoventus Project Ab
Priority to SE0101230A priority Critical patent/SE0101230L/sv
Publication of SE0101230D0 publication Critical patent/SE0101230D0/sv
Priority to DE60227058T priority patent/DE60227058D1/de
Priority to EP02720710A priority patent/EP1372621B1/en
Priority to US10/473,765 priority patent/US20040171563A1/en
Priority to DK02720710T priority patent/DK1372621T3/da
Priority to AT02720710T priority patent/ATE397921T1/de
Priority to PCT/SE2002/000682 priority patent/WO2002080894A1/en
Publication of SE0101230L publication Critical patent/SE0101230L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
SE0101230A 2001-04-06 2001-04-06 Ny användning av en tyrosinkinasinhibitor SE0101230L (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0101230A SE0101230L (sv) 2001-04-06 2001-04-06 Ny användning av en tyrosinkinasinhibitor
DE60227058T DE60227058D1 (sv) 2001-04-06 2002-04-05
EP02720710A EP1372621B1 (en) 2001-04-06 2002-04-05 Novel use of tyrosine kinase frk inhibitor
US10/473,765 US20040171563A1 (en) 2001-04-06 2002-04-05 Novel use of tyrosine kinase inhibitor
DK02720710T DK1372621T3 (da) 2001-04-06 2002-04-05 Hidtil ukendt anvendelse af tyrosinkinase-FRK-inhibitor
AT02720710T ATE397921T1 (de) 2001-04-06 2002-04-05 Neue verwendung von frk-tyrosinekinase inhibitoren
PCT/SE2002/000682 WO2002080894A1 (en) 2001-04-06 2002-04-05 Novel use of tyrosine kinase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101230A SE0101230L (sv) 2001-04-06 2001-04-06 Ny användning av en tyrosinkinasinhibitor

Publications (2)

Publication Number Publication Date
SE0101230D0 SE0101230D0 (sv) 2001-04-06
SE0101230L true SE0101230L (sv) 2002-10-07

Family

ID=20283697

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101230A SE0101230L (sv) 2001-04-06 2001-04-06 Ny användning av en tyrosinkinasinhibitor

Country Status (7)

Country Link
US (1) US20040171563A1 (sv)
EP (1) EP1372621B1 (sv)
AT (1) ATE397921T1 (sv)
DE (1) DE60227058D1 (sv)
DK (1) DK1372621T3 (sv)
SE (1) SE0101230L (sv)
WO (1) WO2002080894A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094682A1 (en) * 2004-10-29 2006-05-04 Odyssey Thera, Inc. Kinase inhibitors for the treatment of diabetes and obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
GB9721437D0 (en) * 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
WO2003022815A1 (en) * 2001-09-10 2003-03-20 Sugen, Inc. 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors

Also Published As

Publication number Publication date
ATE397921T1 (de) 2008-07-15
DE60227058D1 (sv) 2008-07-24
SE0101230D0 (sv) 2001-04-06
EP1372621B1 (en) 2008-06-11
US20040171563A1 (en) 2004-09-02
WO2002080894A1 (en) 2002-10-17
DK1372621T3 (da) 2008-10-20
EP1372621A1 (en) 2004-01-02

Similar Documents

Publication Publication Date Title
HUP0402403A2 (hu) Cukorbetegség-ellenes hatású dipeptilpeptidáz IV (DP-IV) inhibitorok ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MX2010001784A (es) Activadores novedosos de la glucocinasa.
NO20083026L (no) Terapeutisk middel for diabetes
UA88257C2 (ru) ПРИМЕНЕНИЕ ИНГИБИТОРА ПРОТЕИНКИНАЗЫ С-α ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПОЧЕК, КОТОРЫЕ ПРИВОДЯТ К ПРОТЕИНУРИИ, И ДИАБЕТИЧЕСКИМ РЕТИНОПАТИИ, НЕВРОПАТИИ ИЛИ НЕФРОПАТИИ
IS7753A (is) Beta-amínó heterósýklískir dípeptidýl peptíðasa hindrar til meðhöndlunar á, eða til að fyrirbyggja,sykursýki
AU2003282234A1 (en) Benzofuran derivates, process for their preparation and intermediates thereof
MY127961A (en) Beta-amino heterocyclic dipetidyl peptidase inhibitors for the treament or prevention of diabetes
HUP0401998A2 (hu) PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
YU98003A (sh) Supstituisana sulfonamidna jedinjenja, postupak za njihovu upotrebu kao leka za tretiranje poremećaja cns, gojaznosti i dijabetesa tipa ii
ATE424219T1 (de) Hemmende antikörper der her3-aktivität
ATE514435T1 (de) Verwendung eines dpp-iv-hemmers zur minderung hypoglykämischer ereignisse
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
NO20091596L (no) Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer
YU34404A (sh) N-supstituisani derivati pirolidina kao inhibitori dipeptidil-peptidaze iv
EA199901086A1 (ru) ХИНОЛИНОВЫЕ И ХИНОКСАЛИНОВЫЕ СОЕДИНЕНИЯ, ИНГИБИРУЮЩИЕ ТИРОЗИНКИНАЗЫ ТРОМБОЦИТАРНОГО ФАКТОРА РОСТА И/ИЛИ p56
EA201100097A1 (ru) Производные пиразоло[3,4]пиримидин-4-ила и их применения для лечения диабета и ожирения
ATE358668T1 (de) Drogen zur behandlung maligner tumoren
NO20034204D0 (no) Farmasöytiske kombinasjoner til behandling av kreft
PT1268498E (pt) Fosfonatos cardioprotectores
NO20052646L (no) Method of treating cognitive decline due to sleep deprivation and stress
HUP0402506A2 (hu) FBPáz inhibitorok és inzulinérzékenység-fokozók kombinációja diabétesz kezelésére
WO2008156701A3 (en) Hydroxamate inhibitors of insulin-degrading enzyme and uses thereof
DK1599732T3 (da) Fremgangsmåde og præparater til behandling af diagnosticering af diabetes og dermed beslægtede sygdomme som involverer beta-TRP
SE0101230L (sv) Ny användning av en tyrosinkinasinhibitor
TW200608967A (en) Pharmaceutical compositions containing with diabetic agent

Legal Events

Date Code Title Description
NAV Patent application has lapsed